MagVita TMS Therapy w/MagPro R20
FDA 510(k) K172667 · Tonica Elektronik A/S
510(k) numberK172667
Submission
- Device name
- MagVita TMS Therapy w/MagPro R20
- Applicant
- Tonica Elektronik A/S
Farum, DK - Received
- September 5, 2017
- Decision date
- October 5, 2017
- Decision
- Substantially Equivalent (SESE)
- Type
- Special 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- OBP – Transcranial Magnetic Stimulator
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 882.5805
- Specialty
- Neurology
A transcranial magnetic stimulator is a device that delivers brief duration, rapidly alternating, or pulsed, magnetic fields to induce electrical currents that are directed at spatially discrete regions of the cerebral cortex for the treatment of major depressive disorder.
Other 510(k)s with product code OBP
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K260396 | KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A)OBP · Traditional | Fidelity BioPharma Co. | 09/06/2026SE |
| K260691 | BTL-699OBP · Traditional | BTL Industries, Inc. | 08/23/2026SE |
| K261228 | QuickVision Ultimate rTMSOBP · Traditional | Brain Ultimate, Inc. | 08/14/2026SE |
| K260560 | Apollo TMS Therapy System;Apollo light TMS Therapy SystemOBP · Traditional | Mag & More GmbH | 05/22/2026SE |
| K260189 | MagVenture Accelerated TMS (aTMS) Therapy SystemOBP · Traditional | Tonica Elektronik A/S | 05/22/2026SE |
| K253098 | Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)OBP · Traditional | Nexstim Oyj | 03/20/2026SE |
| K252358 | Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)OBP · Traditional | Nexstim Oyj | 03/20/2026SE |
| K251653 | SPRY TMS Therapy System (0550)OBP · Traditional | Soterix Medical, Inc. | 02/20/2026SE |
| K251391 | BrainsWay Deep TMS SystemOBP · Traditional | Brainsway , Ltd. | 11/07/2025SE |
| K250689 | CloudTMS EdgeOBP · Traditional | Teleemg, LLC | 09/14/2025SE |
More from Teleemg, LLC
| 510(k) | Device | Decision |
|---|---|---|
| K260189 | MagVenture Accelerated TMS (aTMS) Therapy SystemOBP · Traditional | 05/22/2026SE |
| K251125 | MagVenture TMS Therapy SystemOBP · Traditional | 08/11/2025SE |
| K251119 | MagVenture TMS Therapy SystemOBP · Traditional | 08/08/2025SE |
| K252032 | T65 (9016E061-)OBP · Special | 07/30/2025SE |
| K230014 | MagVenture Pain Therapy: MagPro R30, MagPro R30 with MagOption, MagPro X100, MagPro X100…QPL · Traditional | 08/25/2023SE |
| K221544 | MagVenture TMS Atlas Neuro Navigation SystemHAW · Traditional | 03/17/2023SE |
| K193006 | MagVenture TMS Therapy for treatment of OCD, MagVenture TMS Therapy systemQCI · Traditional | 08/09/2020SE |
| K173620 | Mag Vita TMS Therapy System w/Theta Burst StimulationOBP · Traditional | 08/14/2018SE |
| K171967 | MagVita TMS Therapy SystemOBP · Special | 07/25/2017SE |
| K171481 | MagVita TMS Therapy SystemOBP · Special | 06/16/2017SE |
Questions and answers
When was MagVita TMS Therapy w/MagPro R20 cleared by the FDA?
MagVita TMS Therapy w/MagPro R20 (K172667) received a 510(k) decision of Substantially Equivalent on October 5, 2017, 30 days after the submission was received.
What is the product code of K172667?
The FDA product code is OBP – Transcranial Magnetic Stimulator, a Class II (moderate risk) device regulated under 21 CFR 882.5805.